ANGPT2 and obesity due to melanocortin 4 receptor deficiency: Beyond HGPS, given the beneficial effects of Ang2 in protecting against insulin resistance and diet-induced weight gain, Ang2 treatment may offer new therapeutic options for the treatment of obesity and metabolic disorders.